Implantable Miniature Telescope for Macular Degeneration

The Implantable Telescope Technology platform is based on wide-angle micro-optics that, in combination with the optics of the cornea, create a telephoto system that magnifies objects in view. VisionCare’s third-generation telescope implant (Implantable Miniature Telescope by Dr. Isaac Lipshitz), has received FDA approval. The company also holds a CE mark and Israel Ministry of Health approval for distribution and sale of the device. The telescope implant is surgically placed in the capsular bag after removal of the eye’s lens. Implantation inside the eye allows the patient to see using natural eye movements in both stationary and dynamic environments.

Implantable Telescope Technology

The Implantable Telescope Technology platform incorporates wide-angle micro-optical lenses in a Galilean telescope design. Based on this proprietary technology, VisionCare’s lead product (Implantable Miniature Telescope by Dr. Isaac Lipshitz), along with the cornea, enlarges images in front of the eye approximately 2.2 or 2.7 times their normal size (depending on the model used). The magnification allows central images to be projected onto healthy perimacular areas of the retina instead of the macula alone, where breakdown of photoreceptors and loss of vision has occurred. This helps reduce the ‘blind spot’ and allows the patient to distinguish and discern images that may have been unrecognizable or difficult to see.

Telescope Implant Construction


The Implantable Telescope Technology is housed in a prosthetic device composed of three primary components: a fused quartz glass capsule that contains wide-angle micro-optical elements; a clear polymethylmethacrylate (PMMA) carrier; and a blue PMMA light restrictor. The sealed optical component is snap-fitted into the carrier plate.